World Parkinson Congress Blog

Posts in Basic Science

Clinical Alpha-Synuclein Biomarker Urgently Needed!

Clinical Alpha-Synuclein Biomarker Urgently Needed!

Thomas G Beach, MD, PhD

Basic ScienceThomas G Beach, MD, PhDJuly 6, 2021Parkinson's, Diagnosis, Alpha-Synuclein, Target engagement, Clinical Trials, Monoclonal Antibody, Biopsy, six Comment

Exercise and Rehabilitation to Move and Live Well

Exercise and Rehabilitation to Move and Live Well

by Natalie Allen, PhD and Serene Paul, PhD

Basic ScienceSerene Paul, PhDJune 1, 2021Parkinson's, exercise, six Comments

In the Nigra, Just Passing Through

In the Nigra, Just Passing Through

by Michael Henderson, PhD

Basic ScienceMichael Henderson, PhDMay 5, 2021Parkinson's, Pathology, sixComment

The Environment & Parkinson’s Disease

The Environment & Parkinson’s Disease

by Briana R. De Miranda, PhD

Basic ScienceBriana R. De Miranda, PhDMarch 29, 2021Environmental Exposure, Neurotoxicant, Pesticides, Solvents, sixComment

The “Black Stuff” and Parkinson’s Disease

The “Black Stuff” and Parkinson’s Disease

by Miquel Vila, MD, PhD

Basic ScienceMiquel Vila, MD, PhDNovember 23, 2020Parkinson's, neuromelanin, fiveComment

The Promise of New Technologies in Research

The Promise of New Technologies in Research

by Christopher G. Sinon, PhD and Stella M. Papa, MD

Clinical Science, Basic ScienceChristopher G. Sinon, PhD and Stella M. Papa, MDMarch 30, 2020Parkinson, Basal ganglia, Optogenetics, Electrophysiology, Striatum, Dopamine, Glutamate, Dyskinesia, fourComment

Does Parkinson’s disease start in the gut or in the brain?

Does Parkinson’s disease start in the gut or in the brain?

by Per Borghammer, MD, PhD, DMSc

Basic SciencePer Borghammer, MD, PhD, DMScSeptember 23, 2019four, gut microbiomeComment

Bacteria and Parkinson's Disease

Bacteria and Parkinson's Disease

by Kathleen M. Shannon, MD

Basic ScienceKathleen M. Shannon, MDJuly 16, 2018three, gut microbiome, bacteria Comment

Accelerating PD Research by Going Back to Basics

Accelerating PD Research by Going Back to Basics

by Marion Delenclos, PhD

Basic ScienceMarion Delenclos, PhDMarch 2, 2018Funding, Research, twoComment

Parkinson's disease, Precision Medicine, and LRRK2

by Matthew Farrer, PhD

Basic ScienceMatthew Farrer, PhDJanuary 22, 2018LRRK2, genetics, personalised medicine, twoComment

The Role of Genetics in Personalized Medicine for Parkinson's Disease

The Role of Genetics in Personalized Medicine for Parkinson's Disease

by Nir Giladi, MD

Basic ScienceNir Giladi MDOctober 11, 2017Personalized Medicine, LRRK2, Genetics, FirstComment

Advice For Those With A Curiosity To Find A Cure For The Shaking Palsy

Advice For Those With A Curiosity To Find A Cure For The Shaking Palsy

by A.J. Lees MD, FRCP, FMedSci

Clinical Science, Basic ScienceA.J. Lees MD, FRCP, FMedSciSeptember 19, 2017Mentor, Research, September 2017, one, FirstComment

Optimism from a Realist

Optimism from a Realist

by Kalpana Merchant, PhD

Basic ScienceKalpana Merchant PhDAugust 7, 2017PPMI, LRRK2, Genetics, August 2017, FirstComment

LRRK2: It’s Not All About The Neurons

LRRK2: It’s Not All About The Neurons

by Darcie A. Cook and Malú G. Tansey, PhD

Basic ScienceDarcie A. Cook PhD CandidateJuly 24, 2017LRRK2, Genetics, Inflammation, Immune System, iPD, FirstComment

To Predict and Prevent

To Predict and Prevent

by Matthew Farrer, PhD

Basic ScienceMatthew Farrer, PhDJuly 17, 2017Micheal J Fox, PPMI, Genetics, LRRK2, GBA, July 2017, FirstComment

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

Developing disease-modifying therapies in Parkinson’s Disease: The buzz about LRRK2 kinase inhibitors

by Andrew B. West, PhD

Photo Credit: Grove Ayers

Basic ScienceAndrew B. West, PhDJuly 10, 2017LRRK2, Michael J Fox, PPMI, Genetics, July 2017, one, FirstComment

Bringing down the barriers: The Latin American Research consortium on the Genetics of Parkinson’s Disease (LARGE-PD)

by Ignacio F. Mata, PhD

Basic ScienceIgnacio F. Mata PhDJune 26, 2017Español, Spanish, Genetics, personalised medicine, LARGE-PD, genetic profile, Parkinson's Disease, parkinson, June 2017, one, FirstComment

Towards an Understanding of the Cognitive Changes in Parkinson's

Towards an Understanding of the Cognitive Changes in Parkinson's

by Javier Castro-Hernández, MD & David Finkelstein, PhD

Basic ScienceJavier Castro-Hernandez MDJune 16, 2017cognition, parkinson, ventral tegmental area, VTA, June 2017, one, FirstComment

The Flu and You: How Viruses Influence the Risk of Parkinson's

The Flu and You: How Viruses Influence the Risk of Parkinson's

by Richard Smeyne, PhD

Basic ScienceRichard Smeyne PhDMay 29, 2017virus, influenze virus, May 2017, One, one, FirstComment

“Tip-of-the-Iceberg” Opportunities in Parkinson’s Disease

“Tip-of-the-Iceberg” Opportunities in Parkinson’s Disease

by Madelyn C. Houser & Malú G. Tansey, PhD

(Photo of Madelyn Houser in the lab.)

Basic ScienceMadelyn C. Houser PhD CandidateMay 15, 2017neuroinflammation, neuroprotection, gut, gut microbiome, non-motor, May 2017, One, one, FirstComment